Literature DB >> 31444574

[High-dose dronabinol treatment vs. medicinal cannabis flowers].

Christoph Wendelmuth1, Knud Gastmeier2.   

Abstract

This article reports a case of pronounced, chronic lumboischialgia, which was not satisfactorily controlled by conventional analgesic treatment. The level of pain under high-dose dronabinol treatment with oral and inhalative administration as well as the way to reimburse the cost of medicinal cannabis flowers, the treatment success and criteria of the economic prescription procedure are presented.

Entities:  

Keywords:  Cannabidiol; Dronabinol; High-dose; Low back pain; Medical marijuana

Mesh：

Substances：

Year:  2019        PMID： 31444574     DOI： 10.1007/s00482-019-00402-7

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


  30 in total

Review 1.  From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis.

Authors:  R Mechoulam; S Ben-Shabat
Journal:  Nat Prod Rep       Date:  1999-04       Impact factor: 13.423

2.  Cannabis is more than simply delta(9)-tetrahydrocannabinol.

Authors:  Ethan B Russo; John M McPartland
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

3.  [Endogenous cannabinoid system. Effect on neuronal plasticity and pain memory].

Authors:  S C Azad; V Huge; P Schöps; C Hilf; A Beyer; H-U Dodt; G Rammes; W Zieglgänsberger
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

4.  Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.

Authors:  M A ElSohly; D F Stanford; E C Harland; A H Hikal; L A Walker; T L Little; J N Rider; A B Jones
Journal:  J Pharm Sci       Date:  1991-10       Impact factor: 3.534

5.  The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.

Authors:  R Brenneisen; A Egli; M A Elsohly; V Henn; Y Spiess
Journal:  Int J Clin Pharmacol Ther       Date:  1996-10       Impact factor: 1.366

Review 6.  Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

Authors:  Suzanne Nielsen; Pamela Sabioni; Jose M Trigo; Mark A Ware; Brigid D Betz-Stablein; Bridin Murnion; Nicholas Lintzeris; Kok Eng Khor; Michael Farrell; Andrew Smith; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2017-03-22       Impact factor: 7.853

Review 7.  Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.

Authors:  M A Huestis
Journal:  Handb Exp Pharmacol       Date:  2005

Review 8.  Modulation of fear and anxiety by the endogenous cannabinoid system.

Authors:  Jasmeer P Chhatwal; Kerry J Ressler
Journal:  CNS Spectr       Date:  2007-03       Impact factor: 3.790

Review 9.  The therapeutic potential of cannabis and cannabinoids.

Authors:  Franjo Grotenhermen; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-07-23       Impact factor: 5.594

10.  Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Authors:  Priyamvada Sharma; Pratima Murthy; M M Srinivas Bharath
Journal:  Iran J Psychiatry       Date:  2012
View more
  1 in total

1.  [Three years of cannabis as medicine-preliminary results of the survey accompanying the prescription of medical cannabis in Germany].

Authors:  Gabriele Schmidt-Wolf; Peter Cremer-Schaeffer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02-09       Impact factor: 1.513
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.